Factor V Leiden Testing: Genetic Clotting Risk
Content last reviewed 2026-09-12 · Educational information — not medical advice
Quick answer
Factor V Leiden mutation (present in ~5% of Caucasians) renders factor V resistant to protein-C inactivation — tripling DVT risk in heterozygotes, 10-20× in homozygotes. Testing belongs after unexplained clots, in young thrombosis, or with strong family clotting history.
The genetic mechanism
Activated protein C normally clips factor V, braking coagulation. Leiden mutation (Arg506Gln) blocks this cleavage site — the brake fails, clotting continues unchecked. Prevalence: ~5% European ancestry, lower in other populations. Homozygous (~1-in-5000) carries substantially higher risk than heterozygous.
Who deserves testing
- First DVT/PE before age 50
- Recurrent thrombosis
- Unusual-site thrombosis (cerebral/splanchnic/mesenteric)
- Strong family history of venous thromboembolism
- Warfarin-induced skin necrosis (protein-C deficiency overlap)
- Women with pregnancy loss + thrombosis history
Testing healthy relatives of known carriers remains debated — disclosure anxiety trades against prevention knowledge.
What testing positive means practically
Heterozygotes: first unprovoked DVT → indefinite anticoagulation typically; provoked DVT → standard 3-month course. Homozygotes: more aggressive prevention thresholds. All carriers: minimize additional risk factors (smoking, estrogen-containing contraceptives/HRT, prolonged immobility).
Management nuance
Estrogen-containing contraception TRIPLES DVT risk in heterozygotes (from 3× baseline to 9×) — alternative contraception strongly recommended in identified carriers. Surgery/hospitalization thromboprophylaxis standard. Pregnancy: antepartum/postpartum prophylaxis decisions by thrombosis history.
Order this test online
Direct-access laboratory testing — no appointment or doctor visit required. Results delivered as secure PDFs.
We may earn a commission when you order through partner links. Educational content only — never a substitute for professional medical advice.
Related guides
Frequently asked questions
Should I test before starting birth control?
Selective screening (family history of clots) recommended; universal screening not — too many needed-to-test for one prevented event.
Does FVL cause heart attacks or strokes?
Arterial thrombosis (MI/stroke) shows weak/absent association — FVL is a VENOUS-clotting risk factor specifically.